Skip to main content
padlock icon - secure page this page is secure

Publisher: Wolters Kluwer

Volume 26, Number 3, March 2016

Pharmacogenetics of multiple sclerosis: personalized therapy with immunomodulatory drugs
pp. 103-115(13)
Authors: Tsareva, Ekaterina; Kulakova, Olga; Boyko, Alexey; Favorova, Olga

Favourites:
ADD

Pharmacogenetic analysis of advanced non-small-cell lung cancer patients treated with first-line paclitaxel and carboplatin chemotherapy
pp. 116-125(10)
Authors: Park, Hyung Soon; Lim, Sun Min; Shin, Ho Jung; Cho, Arthur; Shin, Jae-Gook; Lee, Min Goo; Kim, Hye Ryun; Kim, Joo Hang; Cho, Byoung Chul

Favourites:
ADD

The COL1A1 SP1 polymorphism is associated with lower bone mineral density in patients treated with valproic acid
pp. 126-132(7)
Authors: Villegas-Martínez, Irene; de-Miguel-Elízaga, Irene; Carrasco-Torres, Rubén; Marras, Carlos; Canteras-Jordana, Manuel; Yedra-Guzmán, Maria J.; Martínez-Villanueva, Miriam; Tortosa-Conesa, Diego; Martín-Fernández, Javier

Favourites:
ADD

Association between DPYD c.1129-5923 C>G/hapB3 and severe toxicity to 5-fluorouracil-based chemotherapy in stage III colon cancer patients: NCCTG N0147 (Alliance)
pp. 133-137(5)
Authors: Lee, Adam M.; Shi, Qian; Alberts, Steven R.; Sargent, Daniel J.; Sinicrope, Frank A.; Berenberg, Jeffrey L.; Grothey, Axel; Polite, Blase; Chan, Emily; Gill, Sharlene; Kahlenberg, Morton S.; Nair, Suresh G.; Shields, Anthony F.; Goldberg, Richard M.; Diasio, Robert B.

Favourites:
ADD

PharmGKB summary: very important pharmacogene information for RYR1
pp. 138-144(7)
Authors: Alvarellos, Maria L.; Krauss, Ronald M.; Wilke, Russell A.; Altman, Russ B.; Klein, Teri E.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more